Healthcare worker access to molnupiravir: A case series.

Molnupiravir, an oral antiviral shown to reduce COVID-19 severity, is available in Australia via the Pharmaceutical Benefits Scheme (PBS) for treatment of mild-moderate COVID-19. For people less than 70 years of age it is only available with risk factors for severe disease, hence the majority of hea...

Full description

Bibliographic Details
Main Authors: Jessica C O'Keeffe, Meg Constable, Janice Chiang, Margaret Somerville, Arvind Yerramilli, Ross Nolan, Greg Weeks, Daniel P O'Brien
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2023-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0282695